Education

Bar Admissions

Karen is the Practice Leader of the firm’s Health Law Practice. She counsels health care clients on regulatory, transactional, and operational issues, including Medicare coverage and reimbursement, the development and implementation of health care compliance programs, and licensure and certification matters. In addition, Karen advises clients on the legal, practical, and fraud and abuse implications of business arrangements and sales and marketing practices. Her experience includes matters related to the anti-kickback statute, the Stark law, state statutes prohibiting kickbacks and self-referrals, and the federal Physician Payments Sunshine Act.

Karen applies her compliance and regulatory experience in transactional as well as litigation contexts. In addition to counseling health care entities on regulatory matters arising in connection with mergers and acquisitions, she has successfully defended clients subject to state and federal surveys, Medicare and Medicaid overpayment and reimbursement appeals, and state licensure proceedings. Karen also represents clients subject to state and federal investigations alleging violation of the anti-kickback statute, the federal False Claims Act, and other state and federal laws.

Karen also specializes in the representation of laboratories and diagnostics companies. She regularly counsels on compliance with CLIA and state laboratory licensure laws, federal and state limitations on billing for diagnostic services, and legal restrictions on sales and marketing activities. Karen has served as regulatory counsel in a number of mergers and acquisitions involving laboratories and diagnostics companies and has represented numerous laboratories and diagnostics companies in state and federal government investigations.

Karen has written and lectured on a variety of issues confronting laboratories and others in the health care industry. She is the co-author of What Is…the Anti-Kickback Statute?, a book recently published by the American Bar Association.

Representative Matters

Served as lead counsel to two national independent laboratories in a federal investigation of violations of the federal False Claims Act based on billing and sales/marketing practices as well as quality of care allegations. The government filed a notice of non-intervention, and the parties reached a settlement favorable to the laboratories.

Designed and drafted a diagnostics company’s compliance program policies and conducted general and specialized compliance training programs for employees and board members.

Advised a national independent laboratory on state, federal, and accrediting agency notice and approval requirements in connection with the division of the company and oversaw the preparation of hundreds of filings to be submitted to all licensure and accreditation agencies, the Medicare program, and state Medicaid programs nationwide.

Counseled a specialty laboratory regarding whether and how to make a self-disclosure related to a Medicare overpayment and met with the U.S. Attorney’s Office regarding the self-disclosure, which did not lead to further investigation or enforcement action.

Recognitions & Awards

Chambers USA: District of Columbia – Healthcare (2014 – 2017)

Recognized by The Legal 500 United States for Healthcare: Service Providers (2014 – 2017)

Karen is the Practice Leader of the firm’s Health Law Practice. She counsels health care clients on regulatory, transactional, and operational issues, including Medicare coverage and reimbursement, the development and implementation of health care compliance programs, and licensure and certification matters. In addition, Karen advises clients on the legal, practical, and fraud and abuse implications of business arrangements and sales and marketing practices. Her experience includes matters related to the anti-kickback statute, the Stark law, state statutes prohibiting kickbacks and self-referrals, and the federal Physician Payments Sunshine Act.

Karen applies her compliance and regulatory experience in transactional as well as litigation contexts. In addition to counseling health care entities on regulatory matters arising in connection with mergers and acquisitions, she has successfully defended clients subject to state and federal surveys, Medicare and Medicaid overpayment and reimbursement appeals, and state licensure proceedings. Karen also represents clients subject to state and federal investigations alleging violation of the anti-kickback statute, the federal False Claims Act, and other state and federal laws.

Karen also specializes in the representation of laboratories and diagnostics companies. She regularly counsels on compliance with CLIA and state laboratory licensure laws, federal and state limitations on billing for diagnostic services, and legal restrictions on sales and marketing activities. Karen has served as regulatory counsel in a number of mergers and acquisitions involving laboratories and diagnostics companies and has represented numerous laboratories and diagnostics companies in state and federal government investigations.

Karen has written and lectured on a variety of issues confronting laboratories and others in the health care industry. She is the co-author of What Is…the Anti-Kickback Statute?, a book recently published by the American Bar Association.

Representative Matters

Served as lead counsel to two national independent laboratories in a federal investigation of violations of the federal False Claims Act based on billing and sales/marketing practices as well as quality of care allegations. The government filed a notice of non-intervention, and the parties reached a settlement favorable to the laboratories.

Designed and drafted a diagnostics company’s compliance program policies and conducted general and specialized compliance training programs for employees and board members.

Advised a national independent laboratory on state, federal, and accrediting agency notice and approval requirements in connection with the division of the company and oversaw the preparation of hundreds of filings to be submitted to all licensure and accreditation agencies, the Medicare program, and state Medicaid programs nationwide.

Counseled a specialty laboratory regarding whether and how to make a self-disclosure related to a Medicare overpayment and met with the U.S. Attorney’s Office regarding the self-disclosure, which did not lead to further investigation or enforcement action.

Recognitions & Awards

Chambers USA: District of Columbia – Healthcare (2014 – 2017)

Recognized by The Legal 500 United States for Healthcare: Service Providers (2014 – 2017)

Industries

Create PDF

Include:

Publications

Alerts & Advisories

Industry Reports & Newsletters

Published Articles

Speaking Engagements

Newsroom

Press Releases

In The News

NOTICE:
Please note that contacting Mintz Levin by email, telephone or facsimile will not establish
an attorney-client relationship, obligate us to act as your attorney or respond to you regardless
of the content of your communication. Completion of Mintz Levin's new client and new matter intake
protocol, including without limitation the firm’s conflicts checking process and an engagement letter,
is necessary to establish an attorney-client relationship. Absent a current attorney-client relationship
with Mintz Levin, any information or documents communicated or transmitted by you to Mintz Levin will not
be treated as confidential, secret or protected in any way. If you are not a current client of Mintz Levin,
please do not send any confidential information to us through this web site or otherwise concerning any
potential or actual legal matter you have. Before providing any confidential information to us, you must
obtain permission to do so from one of the firm’s lawyers.

Email This Page

Your privacy is important to us. Mintz Levin uses the names,
e-mail addresses, and notes you provide only to transmit the information you would like to send to us through this page.
We do not sell the information collected through this website to anyone. If you are not a current Mintz Levin client,
please do not include any information that you or another party considers confidential on this form.
Please also see our Disclaimer & Privacy Statement.